Kevin Davies, Editor-in-Chief, Bio-IT and Tessella’s Dr Andrew Chadwick, Principle Consultant, Life Sciences and Health Care discuss Translational Medicine. Listen to this podcast and learn about:

• Effective, ethical approaches to trial design that harness incompletely validated predictive and prognostic biomarkers
• Ways to improve the value of image information and other rich data
• The tradeoffs to expect in using biomarkers for early go/no-go decisions
• How graphical models of risk and uncertainty can help the business, portfolio and functional teams to jointly leverage these exciting TM opportunities

To listen to the podcast click here

This entry was posted in News & Events.